Journal of the Peripheral Nervous System

Papers
(The median citation count of Journal of the Peripheral Nervous System is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Abstracts61
39
35
27
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study24
PNS Abstracts 202321
Toxic medications in Charcot–Marie–Tooth patients: A systematic review20
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”18
17
Nerve ultrasound as a screening tool for inherited sensory neuronopathy17
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy17
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort16
Ofatumumab for treating autoimmune nodopathy14
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders14
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice14
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study13
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials13
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)13
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy13
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy13
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy12
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology12
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)12
Issue Information11
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy11
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei10
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study9
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods9
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China9
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency9
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version9
Nerve biopsy in acquired neuropathies8
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A8
8
Issue Information8
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis8
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision8
Techniques for the standard histological and ultrastructural assessment of nerve biopsies8
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy8
Issue Information8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes7
Issue Information7
7
Issue Information7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response6
ABSTRACT6
The autoimmune vulnerability of the node of Ranvier6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy6
Issue Information6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po6
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)6
6
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy6
6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers6
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience5
5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy5
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers4
2021 Peripheral Nerve Society virtual event4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?4
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?4
Anxiety and depression in small fiber neuropathy4
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies3
Issue Information3
3
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis3
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort3
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy3
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor3
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies3
Issue Information3
Issue Information3
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis3
Issue Information3
Issue Information3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review3
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action3
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era3
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies2
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus2
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves2
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN12
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy2
Leptospirosis‐induced acute acquired inflammatory neuropathy2
Unusual upper limb features in SORD neuropathy2
2
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria2
2
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy2
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report2
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation2
Identification of cellular and noncellular components of mature intact human peripheral nerve2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor2
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders2
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal2
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla2
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa2
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease2
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review2
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome2
Abstract2
Etiologic Diagnosis of Neuropathies Based on First‐Line Screening of TTR Gene Mutations2
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System1
1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy1
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy1
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course1
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?1
1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy1
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome1
Issue Information1
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset1
Issue Information1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents1
Abstract1
Issue Information1
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)1
Sural nerve biopsy utility by masked assessment of individual histologic preparations1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”1
1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges1
Serum neurofilament light chain measurements following nerve trauma1
Issue Information1
Issue Information1
Normal structure and pathological features in peripheral neuropathies1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome1
Issue Information1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy1
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome1
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response1
1
Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A11
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study1
Laura Feltri: In memoriam1
Issue Information1
0.050410032272339